chitosan has been researched along with rasagiline in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aditya, N; Cherian, L; Patil, S; Ravi, PR | 1 |
| Ali, A; Ali, J; Baboota, S; Fazil, M; Hasan, Q; Md, S; Mittal, D | 1 |
| Rohith, G; Satheesha Babu, BK | 1 |
| Abbas Hussein, A; Abdelamir Mohammad, H; Alsaraf, KM; Mahde, BW | 1 |
4 other study(ies) available for chitosan and rasagiline
| Article | Year |
|---|---|
Nasal in-situ gels for delivery of rasagiline mesylate: improvement in bioavailability and brain localization.
Topics: Acrylates; Administration, Intranasal; Animals; Biological Availability; Brain; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Liberation; Female; Gels; Indans; Male; Neuroprotective Agents; Poloxamer; Rabbits; Rats; Rats, Wistar; Temperature; Tissue Distribution; Transition Temperature | 2015 |
Brain targeted nanoparticulate drug delivery system of rasagiline via intranasal route.
Topics: Administration, Intranasal; Animals; Biological Availability; Brain; Chemistry, Pharmaceutical; Chitosan; Drug Compounding; Drug Delivery Systems; Goats; Indans; Male; Mice; Nanoparticles; Nasal Mucosa; Neuroprotective Agents; Parkinson Disease; Tissue Distribution | 2016 |
Influence of chitosan thioglycolic acid conjugate in improving bioavailability of an antiparkinson drug; Rasagiline Mesylate from transdermal patch.
Topics: Administration, Cutaneous; Biological Availability; Chitosan; Indans; Mesylates; Skin; Tablets; Thioglycolates; Transdermal Patch | 2021 |
Transdermal Microneedle-Mediated Delivery of Rasagiline Nanoparticles.
Topics: Administration, Cutaneous; Animals; Chitosan; Nanoparticles; Skin | 2023 |